News

Learn more about the latest in science, research and innovation from Germany. Also find useful information about research opportunities and development grants in India and Germany.

Project Impact – Impact of COVID-19 on Cities and Mobility

While the consequences of the COVID-19 pandemic are still unravelling, there is wide consensus already on one aspect: this crisis will impact urban living, businesses and technology in a manner that suggests such disruptions could become the new normal. Further, it will require a paradigm shift in current approaches to cope with them.
Horizon 2020: Results of IMI Fast-Track Call for Covid-19

On 3 March 2020, the Innovative Medicines Initiative (IMI) supported through the European Commission’s Horizon 2020 Framework Programme for Research and Innovation, launched a special fast-track call for the “Development of therapeutics and diagnostics combating coronavirus infections” with an EU contribution of €45 million, which was subsequently increased to €72 million.
Tackling COVID-19: Developments in Germany
Coronavirus Global Response pledging event: Germany pledges €525 million in the fight against COVID-19

The European Union and its partners hosted an international pledging marathon on Monday 4 May 2020 to gather significant funding to ensure the collaborative development and universal deployment of diagnostics, treatments and vaccines against coronavirus.
Tackling COVID-19: Developments in Germany
Germany announces first coronavirus vaccine trial

German Health Minister Jens Spahn has announced the first clinical trials of a coronavirus vaccine. The Paul Ehrlich Institute (PEI), the regulatory authority which helps develop and authorizes vaccines in Germany, has given the go-ahead for the first clinical trial of BNT162b1, a vaccine against the SARS-CoV-2 virus. It was developed by cancer researcher and immunologist Ugur Sahin and his team at pharmaceutical company BioNTech, and is based on their prior research into cancer immunology.
Tackling COVID-19: Developments in Germany
DZIF Coronavirus Researchers use “Fast Track”

Research has been called to develop drugs, vaccines and testing methods as quickly as possible to fight the SARS–coronavirus-2. A fast-track procedure has made additional funding available to scientists at the German Center for Infection Research (DZIF) for this purpose.
Tackling COVID-19: Developments in Germany
SARS-CoV-2: DZIF scientists and the development of vaccines

Scientists and physicians at the German Center for Infection Research (DZIF) have been working towards developing a vaccine against the novel coronavirus as rapidly as possible. Here is a glimpse of the developments.
Application period for Green Talents award 2020 now open

Are you an up-and-coming researcher with ground-breaking visions to create a better and more sustainable future for all? Is your research dedicated to realise the United Nations Sustainable Development Goals (SDGs)? Do you have the potential to change the world?